We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
President Biden signed into law a $1.7 trillion omnibus spending package on Dec. 23, appropriating $3.5 billion in discretionary funding for the FDA through Sept. 30, 2023 — an increase of $226 million, or 6.5 percent, from what was enacted for the agency in 2022. Read More
Ibex Medical Analytics’s Galen Breast artificial intelligence (AI) diagnostic tool showed high accuracy in detecting breast cancer from biopsies, researchers reported in the journal Breast Cancer. Read More
The FDA has identified Arrow International’s Oct. 17 recall of its intra-aortic balloon pumps as Class 1 because the device’s short battery life may cause serious injury or death. Read More
Philips said Wednesday that independent testing on its recalled DreamStation devices showed that exposure from degraded sound abatement foam on the devices is unlikely to result in “appreciable harm” to patient health. Read More